| 臺大學術典藏 |
2022-09-06T07:43:04Z |
Hepatic resection for hepatocellular carcinoma patients on hemodialysis for Uremia: A nationwide cohort study
|
Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Charalampos I.; Chen T.-T.; Lee T.-Y.; MING-SHIANG WU; Kuo K.N.; Liu Y.-Y.; Wu C.-Y. |
| 臺大學術典藏 |
2022-03-10T05:59:46Z |
Anatomical Asymmetry in Goiter: A Demonstration by Three-dimensional Power Doppler Ultrasound
|
Hsieh M.-H.; Chiou S.-C.; Chen C.-C.; Hsu W.-H.; Jeng L.-B.; YI-CHENG CHANG; Lin J.-D. |
| 臺大學術典藏 |
2022-03-10T05:59:36Z |
Adverse outcomes after noncardiac surgery in patientswith diabetes: A nationwide population-based retrospective cohort study
|
Yeh C.-C.; Liao C.-C.; YI-CHENG CHANG; Jeng L.-B.; Yang H.-R.; Shih C.-C.; Chen T.-L. |
| 臺大學術典藏 |
2022-01-24T09:32:03Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
CHUN-JEN LIU; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2022-01-24T09:31:38Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
CHUN-JEN LIU; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2021-09-01T01:53:44Z |
Brivanib versus sorafenib as first-line therapy in patients with unresectable, advanced hepatocellular carcinoma: Results from the randomized phase III BRISK-FL study
|
Johnson P.J.; Qin S.; Park J.-W.; Poon R.T.P.; Raoul J.-L.; Philip P.A.; Hsu C.-H.; Hu T.-H.; Heo J.; Xu J.; Lu L.; Chao Y.; Boucher E.; Han K.-H.; Paik S.-W.; Robles-Avi?a J.; Kudo M.; Yan L.; Sobhonslidsuk A.; Komov D.; Decaens T.; Tak W.-Y.; Jeng L.-B.; Liu D.; Ezzeddine R.; Walters I.; ANN-LII CHENG |
| 臺大學術典藏 |
2021-07-03T03:34:53Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:30Z |
Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen L.-T.; Chen M.-F.; Li L.-A.; Lee P.-H.; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-07-03T03:34:06Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Liu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; PEI-JER CHEN |
| 臺大學術典藏 |
2021-06-01T07:03:27Z |
Osteoblast-derived TGF-β1 stimulates IL-8 release through AP-1 and NF-κB in human cancer cells
|
Fong Y.-C.; Maa M.-C.; Tsai F.-J.; Chen W.-C.; Lin J.-G.; Jeng L.-B.; Yang R.-S.; WEN-MEI FU; Tang C.-H. |
| 臺大學術典藏 |
2021-05-31T02:57:26Z |
Osteoblast-derived TGF-β1 stimulates IL-8 release through AP-1 and NF-κB in human cancer cells
|
Fong Y.-C.; Maa M.-C.; Tsai F.-J.; Chen W.-C.; Lin J.-G.; Jeng L.-B.; RONG-SEN YANG; Fu W.-M.; Tang C.-H. |
| 臺大學術典藏 |
2021-03-18T05:59:32Z |
The accuracy of ultrasonography and 201Tl-99mTc subtraction scan in localization of parathyroid lesions.
|
Liou M.J.; Huang H.S.; Lin J.D.; Huang B.Y.; Hsueh C.; Jeng L.B.; KAI-YUAN TZEN |
| 臺大學術典藏 |
2021-02-02T02:21:32Z |
Hepatic resection for hepatocellular carcinoma patients on hemodialysis for Uremia: A nationwide cohort study
|
Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Charalampos I.; Chen T.-T.; Lee T.-Y.; MING-SHIANG WU; Kuo K.N.; Liu Y.-Y.; Wu C.-Y. |
| 臺大學術典藏 |
2021-02-02T02:21:22Z |
Nonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: A nationwide cohort study
|
Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Ho H.J.; Yang H.-R.; MING-SHIANG WU; Kuo K.N.; Wu C.-Y. |
| 臺大學術典藏 |
2020-11-19T03:19:55Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2020-11-19T03:19:36Z |
Long-term results of a randomized, observation-controlled, phase III Trial of Adjuvant Interferon alfa-2b in hepatocellular carcinoma after curative resection
|
Chen L.-T.;Chen M.-F.;Li L.-A.;Po-Huang Lee;Jeng L.-B.;Lin D.-Y.;Wu C.-C.;Mok K.-T.;Chen C.-L.;Lee W.-C.;Chau G.-Y.;Chen Y.-S.;Lui W.-Y.;Hsiao C.-F.;Whang-Peng J.;Chen P.-J.; Chen L.-T.; Chen M.-F.; Li L.-A.; PO-HUANG LEE; Jeng L.-B.; Lin D.-Y.; Wu C.-C.; Mok K.-T.; Chen C.-L.; Lee W.-C.; Chau G.-Y.; Chen Y.-S.; Lui W.-Y.; Hsiao C.-F.; Whang-Peng J.; Chen P.-J. |
| 臺大學術典藏 |
2020-11-19T03:19:23Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; Ho M.-C.; Yang S.-S.; Yang M.-D.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J.; Liu C.-J.; Chang J.; PO-HUANG LEE; Lin D.-Y.; Wu C.-C.; Jeng L.-B. |
| 臺大學術典藏 |
2020-11-19T03:19:19Z |
Pre-existing diabetes and risks of morbidity and mortality after liver transplantation: A nationwide database study in an Asian population
|
PO-HUANG LEE; Jeng L.-B.; Kao C.-H.; Wang H.-H.; Wang Y.-C.; Tsai M.-S. |
| 臺大學術典藏 |
2020-11-02T02:04:43Z |
Hepatic resection for hepatocellular carcinoma patients on hemodialysis for Uremia: A nationwide cohort study
|
Wu C.-Y.; Liu Y.-Y.; Kuo K.N.; Yeh C.-C.; Lin J.-T.; Jeng L.-B.; Charalampos I.; Chen T.-T.; Lee T.-Y.; MING-SHIANG WU |
| 臺大學術典藏 |
2020-02-26T01:33:18Z |
Large-scale bicortical skull bone regeneration using ex vivo replication-defective adenoviral-mediated bone morphogenetic protein-2 gene-transferred bone marrow stromal cells and composite biomaterials
|
Chang, S.C.-N.; Lin, T.-M.; Chung, H.-Y.; Chen, P.K.-T.; Lin, F.-H.; Lou, J.; Jeng, L.-B.; FENG-HUEI LIN |
| 臺大學術典藏 |
2020-02-24T05:13:06Z |
Long-term risk of acute coronary syndrome in splenectomized patients due to splenic injury
|
Tsai M.-S.; Chou S.-E.; HONG-SHIEE LAI; Jeng L.-B.; Lin C.-L.; Kao C.-H. |
| 臺大學術典藏 |
2020-02-19T09:33:57Z |
Heparanase inhibitor PI-88 as adjuvant therapy for hepatocellular carcinoma after curative resection: A randomized phase II trial for safety and optimal dosage
|
Liu C.-J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin P.-W.; Mok K.-T.; Lee W.-C.; Yeh H.-Z.; MING-CHIH HO; Yang S.-S.; Lee C.-C.; Yu M.-C.; Hu R.-H.; Peng C.-Y.; Lai K.-L.; Chang S.S.-C.; Chen P.-J. |
| 臺大學術典藏 |
2020-02-19T09:33:45Z |
Adjuvant heparanase inhibitor PI-88 therapy for hepatocellular carcinoma recurrence
|
Chen P.-J.; Chang S.S.-C.; Lai K.-L.; Peng C.-Y.; Hu R.-H.; Yu M.-C.; Yang M.-D.; Yang S.-S.; MING-CHIH HO; Liu C.-J.; Chang J.; Lee P.-H.; Lin D.-Y.; Wu C.-C.; Jeng L.-B.; Lin Y.-J.; Mok K.-T.; Lee W.-C.; Yeh H.-Z. |
| 國立成功大學 |
2020 |
Detection of hepatitis B virus pre-S mutants in plasma by a next-generation sequencing-based platform determines their patterns in liver tissues
|
Teng, C.-F.;Tsai, H.-W.;Li, T.-C.;Wang, T.;Wang, J.;Shyu, W.-C.;Wu, H.-C.;Su, I.-J.;Jeng, L.-B. |
| 臺大學術典藏 |
2018-09-10T09:47:18Z |
Adverse outcomes after noncardiac surgery in patientswith diabetes: A nationwide population-based retrospective cohort study
|
Yeh, C.-C.;Liao, C.-C.;Chang, Y.-C.;Jeng, L.-B.;Yang, H.-R.;Shih, C.-C.;Chen, T.-L.Yeh, Chun-Chieh;Liao, Chien-Chang;Chang, Yi-Cheng;Jeng, Long-Bin;Yang, Horng-Ren;Shih, Chun-Chuan;Chen, Ta-Liang; Yeh, Chun-Chieh;Liao, Chien-Chang;Chang, Yi-Cheng;Jeng, Long-Bin;Yang, Horng-Ren;Shih, Chun-Chuan;Chen, Ta-Liang; Yeh, Chun-Chieh; YI-CHENG CHANG; Liao, Chien-Chang; Chang, Yi-Cheng; Jeng, Long-Bin; Yang, Horng-Ren; Shih, Chun-Chuan; Chen, Ta-Liang |
| 臺大學術典藏 |
2018-09-10T08:13:36Z |
Anatomical Asymmetry in Goiter: A Demonstration by Three-dimensional Power Doppler Ultrasound
|
Hsieh, M.-H.;Chiou, S.-C.;Chen, C.-C.;Hsu, W.-H.;Jeng, L.-B.;Chang, Y.-C.;Lin, J.-D.; YI-CHENG CHANG |
| 臺大學術典藏 |
2015 |
Nonsteroidal anti-inflammatory drugs are associated with reduced risk of early hepatocellular carcinoma recurrence after curative liver resection: A nationwide cohort study
|
Wu C.-Y.; Kuo K.N.; MING-SHIANG WU; Yang H.-R.; Ho H.J.; Jeng L.-B.; Lin J.-T.; Yeh C.-C. |
| 國立成功大學 |
2007 |
Novel heparanase inhibitor PI-88 extends disease free survival in a randomized phase II adjuvant clinical trial in patients with hepatocellular carcinoma (HCC) after curative resection
|
Chen, P. J.; Lee, P. H.; Lin, D. Y.; Wu, C. C.; Jeng, L. B.; Lin, Pin-Wen; Mok, K. T.; Gautam, A. M.; Zalebergg, J. R. |
